SLS

SLS

USD

SELLAS Life Sciences Group Inc. Common Stock

$1.680-0.070 (-4.000%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.750

最高

$1.770

最低

$1.670

交易量

2.79M

公司基本面

市值

247.7M

行業

生物科技

國家

United States

交易統計

平均交易量

3.07M

交易所

NCM

貨幣

USD

52週範圍

最低 $0.77當前 $1.680最高 $2.48

相關新聞

GlobeNewswire

SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for

查看更多
SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting